-
A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial
Andriessen, C., Blom, M. T., van Hoek, B. A. C. E., de Boer, A. W., Denig, P., de Wit, G. A., Swart, K., de Rooij-Peek, A., van Marum, R. J., Hugtenburg, J. G., Slottje, P., van Raalte, D., van Bloemendaal, L., Herings, R., Nijpels, G., Vos, R. C. & Elders, P. J. M., 25 Jul 2024, In: Trials. 25, 1, p. 505 505.Research output: Contribution to journal › Article › Academic › peer-review
-
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe
Brobert, G., Ruigomez, A., Schink, T., Voss, A., Herings, R., Smits, E., Swart, K. M. A., Friberg, L., Balabanova, Y., Tarenz, C., Suzart-Woischnik, K., Soriano-Gabarró, M., Vora, P., Homering, M., Dyszynski, T., Nagel, G., Amaya, P. & García Rodríguez, L. A., 25 Mar 2024, In: BMJ Open. 14, 3, p. e081348 e081348.Research output: Contribution to journal › Review article › Academic › peer-review
-
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries
Ruigómez, A., Schink, T., Voss, A., Herings, R. M. C., Smits, E., Swart-Polinder, K., Balabanova, Y., Brobert, G., Suzart-Woischnik, K. & Rodríguez, L. A. G., 1 Mar 2024, In: PLOS ONE. 19, 3 March, e0298596.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
